Ogawa, K., Ito, J., Fujimoto, D., Morita, M., Yoshizumi, Y., Ariyoshi, K., … Katakami, N. (2018). Exacerbation of autoimmune hemolytic anemia induced by the first dose of programmed death-1 inhibitor pembrolizumab: a case report. Investigational New Drugs. https://doi.org/10.1007/s10637-018-0561-5 (Original work published 2018)